Novo Nordisk A/S (NVO)
NYSE·Healthcare·Drug Manufacturers - General
$44.07
+0.28%
Mkt Cap $176.82B
Analyst Ratings
No recent rating data.
Price Target (16 analysts)
$47.00
Range $42.00 – $54.00
Implied Upside
+6.6%
Consensus $47.00 vs current $44.07
NYSE·Healthcare·Drug Manufacturers - General
$44.07
+0.28%
Mkt Cap $176.82B
No recent rating data.
Price Target (16 analysts)
$47.00
Range $42.00 – $54.00
+6.6%
Consensus $47.00 vs current $44.07